Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GlucoTrack, Inc. (GCTK : NSDQ)

• Company Description    GlucoTrack Inc. is an innovator of GlucoTrack(R), a non-invasive device and digital health platform for measuring glucose levels in people with Type 2 diabetes and prediabetes. GlucoTrack Inc., formerly known as Integrity Applications Inc., is based in Rutherford, NJ. Number of Employees: 11

• Price / Volume Information    Yesterday's Closing Price: $5.85 Daily Weekly Monthly 20 Day Moving Average: 1,622,122 shares Shares Outstanding: 0.48 (millions) Market Capitalization: $2.80 (millions) Beta: -0.24 52 Week High: $3,756.00 52 Week Low: $5.16 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.75% -11.20% 12 Week -38.56% -48.32% Year To Date -98.69% -98.77%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 ROUTE 17 NORTH SUITE 800 - RUTHERFORD,NJ 07070 USA ph: 201-842-7715 fax: - investors@glucotrack.com http://www.glucotrack.com

• General Corporate Information    Officers Paul Goode - Chief Executive Officer and Director Peter Wulff - Chief Financial Officer Erin Carter - Director Luis Malave - Director Robert Fischell - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45824Q804 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 0.48 Most Recent Split Date: 6.00 (0.02:1) Beta: -0.24 Market Capitalization: $2.80 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.34 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 97.17% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -544.87 12/31/24 - -954.27 Current Ratio 06/30/25 - - 03/31/25 - 4.85 12/31/24 - 4.52 Quick Ratio 06/30/25 - - 03/31/25 - 4.85 12/31/24 - 4.52 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 16.99 12/31/24 - -983.43 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.03 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - 2.69 12/31/24 - -

Powered by Zacks Investment Research ©